Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib +/- cobimetinib: a pooled analysis of four clinical trials

Ascierto, PA; Ribas, A; Larkin, J; McArthur, GA; Lewis, KD; Hauschild, A; Flaherty, KT; McKenna, E; Zhu, Q; Mun, Y; Dreno, B

Ascierto, PA (corresponding author), Ist Nazl Tumori IRCCS Fdn G Pascale, Via Mariano Semmola, I-80131 Naples, Italy.

JOURNAL OF TRANSLATIONAL MEDICINE, 2020; 18 (1):

Abstract

BackgroundWe sought to identify patient subgroups with distinct postprogression overall survival (ppOS) outcomes and investigate the impact of origina......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索